Skip to content

维京治疗

US · VKTX #2352 按市值排名 上市于 2015
25.17 -2.20 -8.04%
实时 - 追踪5344个代码 - 心跳于402秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 最近一期（2026/Q3）披露持股的机构数量减少了1家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
65.69% -0.02pp
机构数量
504 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund43.74%
Hedge Fund12.06%
Public Company5.75%
Private Company3.17%
Individual/Insider2.46%
Government Pension Fund0.48%
Family Office/Trust0.21%
VC/PE Fund0.17%
Other31.89%

主要股东 截至 2026-06-30

FMR 5.40% · 6.30M 股
BlackRock 5.31% · 6.19M 股
Vanguard Capital Management, LLC 4.96% · 5.79M 股
State Street Global Advisors 4.81% · 5.61M 股
Vanguard Portfolio Management, LLC 3.84% · 4.48M 股
Two Sigma Investments, LP 3.38% · 3.94M 股
Morgan Stanley 2.73% · 3.19M 股
Brian Lian 1.90% · 2.22M 股
Columbia Management Investment Advisers, LLC 1.85% · 2.16M 股
Geode Capital Management, LLC 1.80% · 2.10M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 36次买入 · 14次卖出

姓名职务持股比例
Brian Lian Chief Executive Officer 1.90%
Marianne Mancini Chief Operating Officer 0.27%
Matthew Foehr Independent Director 0.11%
Gregory Zante Chief Financial Officer 0.10%
Lawson MacArtney Independent Chairperson 0.04%
Charles Rowland Independent Director 0.03%
J. Singleton Independent Director 0.01%
Neil Aubuchon Chief Commercial Officer 0.00%
Sarah Rouan Independent Director 0.00%
Hubert Chen Chief Medical Officer --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-07-31 Dorothy Gemmell Director Other Acquisition +6,333 --
2026-07-31 Dorothy Gemmell Director Other Derivative Acquisition +40,800 $31.74
2026-07-28 Gregory Zante Chief Financial Officer Open Market Disposition -21,217 $33.47
2026-07-28 Brian Lian Chief Executive Officer Open Market Disposition -148,517 $33.32
2026-07-28 Marianne Mancini Chief Operating Officer Open Market Disposition -18,217 $33.47
2026-07-27 Gregory Zante Chief Financial Officer Other Acquisition +31,667 --
2026-07-27 Brian Lian Chief Executive Officer Other Acquisition +221,667 --
2026-07-27 Marianne Mancini Chief Operating Officer Other Acquisition +31,667 --
2026-05-31 Hubert Chen Chief Medical Officer Other Derivative Acquisition +190,000 $31.27
2026-03-09 Neil Aubuchon Chief Commercial Officer Open Market Acquisition +4,475 $33.50
2026-01-11 Neil Aubuchon Chief Commercial Officer Other Derivative Acquisition +180,000 $31.76
2026-01-04 Gregory Zante Chief Financial Officer Other Acquisition +41,000 --
2026-01-04 Gregory Zante Chief Financial Officer Open Market Disposition -57,661 $32.09–34.24
2026-01-04 Brian Lian Chief Executive Officer Other Acquisition +78,400 --
2026-01-04 Brian Lian Chief Executive Officer Open Market Disposition -233,409 $32.29–35.07
2026-01-04 Marianne Mancini Chief Operating Officer Other Acquisition +41,000 --
2026-01-04 Marianne Mancini Chief Operating Officer Open Market Disposition -57,661 $32.29–35.07
2026-01-01 Matthew Foehr Independent Director Other Acquisition +3,150 --
2026-01-01 Matthew Foehr Independent Director Derivative Exercise and Sale -16,000 $3.33–35.11
2026-01-01 Matthew Foehr Independent Director Other Derivative Acquisition +20,400 $35.42

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:22 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

维京治疗 讨论区 0 条评论

发表评论